Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,172 GBX | +1.54% | +4.81% | -30.37% |
May. 23 | CVS Group says will back investigation by UK CMA into pet market | AN |
May. 23 | CVS Group Signals Cooperation for UK Watchdog's Investigation into Veterinary Sector | MT |
Strengths
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- The company appears highly valued given the size of its balance sheet.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- CVSG Stock
- Ratings CVS Group plc